John B. Fiveash

John Fiveash practices at University of Alabama Birmingham Hospital in Birmingham, Alabama.

John Fiveash's NPI, 1700820339, was assigned on June 15, 2006. John Fiveash graduated from Medical College of Georgia in 1993. John Fiveash's Alabama license number on file is 32484.

John Fiveash's primary practice is University of Alabama Birmingham Hospital, at 619 19th S St, Birmingham, AL 35211 in Jefferson County. The practice phone is (205) 731-9770.

John Fiveash's primary practice is University of Alabama Birmingham Hospital in Birmingham, Alabama. John Fiveash is also affiliated with UAB Hospital. The medical group on file is UAB Medicine. Dmand AI also links John Fiveash to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where John Fiveash practices. Vendor and product names are available with a free account.

Neurological surgery is John Fiveash's primary specialty in the NPI Registry, under taxonomy code 207T00000X. John Fiveash is board certified in radiation oncology by the American Board of Radiology. Dmand AI has John Fiveash's licenses on file in 4 states: Alabama, Michigan, Georgia and South Carolina.

Dmand AI lists bone cancer radiation, brain cancer radiation, brain tumor radiation, lung cancer radiation, lymphoma radiation and prostate cancer radiation among the conditions John Fiveash treats.

CMS data shows 650 Medicare services from John Fiveash across 14 procedure codes in 2024, for 183 Medicare patients. Medicare paid $65,441 for them.

CMS counts 183 Medicare patients who saw John Fiveash in 2024. The largest group is 65 to 74, with 89 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.99, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts John Fiveash's median patient age at 65, with 50% women.

In 2024, John Fiveash wrote 98 Medicare Part D claims for 37 patients. 90% of them were for generic drugs. CMS names the drug for 15 of them, across 1 drug with 11 or more claims each, at $252 in total drug cost. In 2023, CMS named 16 claims across 1 drug.

John Fiveash accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists John Fiveash as offering telehealth.

Dmand AI links 114 papers to John Fiveash, published from 2009 to 2025. 2019 was the busiest year, with 14. The most frequent topics are Brain Neoplasms, Radiosurgery and Radiotherapy Planning, Computer-Assisted. John Fiveash has published most often in Adv Radiat Oncol. John Fiveash's most frequent co-authors are Markus Bredel, MD, PhD, Evan M. Thomas, MD, PhD and Kristen O. Riley.

Dmand AI links John Fiveash to 13 clinical trials, 4 of them phase 1 studies. 1 is still active or recruiting. Conditions studied include Glioblastoma, Gliosarcoma and Brain Neoplasms. University of Alabama at Birmingham sponsors the most, 4.

CMS Open Payments shows 117 general payments to John Fiveash from 5 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 31% of the total. Varian Medical Systems, Inc. paid the most, $20,538.

Dmand AI lists 3 awards for John Fiveash, most recently America's Top Doctors in 2014.

John Fiveash graduated from Medical College of Georgia in 1993. John Fiveash is a member of ASCO.

John Fiveash is in network with 13 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.